Atlas Trials

Shanghai Yunying Medical Technology

8 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Shanghai Yunying Medical Technology

RecordFirmDate
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Bone and Soft Tissue Tumors (NCT06171282)Shanghai Yunying Medical Technology2023-07-12
A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors (NCT05961111)Shanghai Yunying Medical Technology2023-06-24
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Bone and Soft Tissue Tumors (NCT05851456)Shanghai Yunying Medical Technology2023-04-10
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors (NCT05886075)Shanghai Yunying Medical Technology2023-03-30
A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Relapsed/Refractory Head and Neck Cancer (NCT05830240)Shanghai Yunying Medical Technology2023-03-27
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors (NCT05860374)Shanghai Yunying Medical Technology2023-03-02
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Cervical and Endometrial Cancer (NCT05812677)Shanghai Yunying Medical Technology2023-02-06
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Ovarian Cancer (NCT05801783)Shanghai Yunying Medical Technology2022-12-02

Track Shanghai Yunying Medical Technology automatically

Every clearance here is in the API, with alerts when new ones post.